摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

Pyrazine-2-carboximidic acid methyl ester hydrochloride | 1154063-17-8

中文名称
——
中文别名
——
英文名称
Pyrazine-2-carboximidic acid methyl ester hydrochloride
英文别名
methyl pyrazine-2-carboximidate;hydrochloride
Pyrazine-2-carboximidic acid methyl ester hydrochloride化学式
CAS
1154063-17-8
化学式
C6H7N3O*ClH
mdl
——
分子量
173.602
InChiKey
XILVASLTMBNODA-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    0.87
  • 重原子数:
    11
  • 可旋转键数:
    2
  • 环数:
    1.0
  • sp3杂化的碳原子比例:
    0.17
  • 拓扑面积:
    58.9
  • 氢给体数:
    2
  • 氢受体数:
    4

反应信息

  • 作为反应物:
    描述:
    1,1-双(4-氟苯基)-1,2-乙二胺Pyrazine-2-carboximidic acid methyl ester hydrochloride甲醇 为溶剂, 以64%的产率得到4,4-Bis(4-fluorophenyl)-2-pyrazinyl-2-imidazoline
    参考文献:
    名称:
    Discovery of substituted 2,4,4-triarylimidazoline derivatives as potent and selective neuropeptide Y Y5 receptor antagonists
    摘要:
    Novel imidazoline derivatives were discovered to be potent neuropeptide Y Y5 receptor antagonists. High-throughput screening of Merck sample collections against the human Y5 receptor resulted in the identification of 2,4,4-triphenylimidazoline (1), which had an IC(50) of 54 nM. Subsequent optimization led to the identification of several potent derivatives. (C) 2009 Elsevier Ltd. All rights reserved.
    DOI:
    10.1016/j.bmcl.2009.01.101
  • 作为产物:
    参考文献:
    名称:
    Discovery of substituted 2,4,4-triarylimidazoline derivatives as potent and selective neuropeptide Y Y5 receptor antagonists
    摘要:
    Novel imidazoline derivatives were discovered to be potent neuropeptide Y Y5 receptor antagonists. High-throughput screening of Merck sample collections against the human Y5 receptor resulted in the identification of 2,4,4-triphenylimidazoline (1), which had an IC(50) of 54 nM. Subsequent optimization led to the identification of several potent derivatives. (C) 2009 Elsevier Ltd. All rights reserved.
    DOI:
    10.1016/j.bmcl.2009.01.101
点击查看最新优质反应信息

文献信息

  • Experimental Chemotherapy of Tuberculosis. II. The Synthesis of Pyrazinamides and Related Compounds<sup>1</sup>
    作者:S. Kushner、H. Dalalian、J. L. Sanjurjo、F. L. Bach、S. R. Safir、V. K. Smith、J. H. Williams
    DOI:10.1021/ja01134a045
    日期:1952.7
  • Discovery of substituted 2,4,4-triarylimidazoline derivatives as potent and selective neuropeptide Y Y5 receptor antagonists
    作者:Nagaaki Sato、Makoto Jitsuoka、Shiho Ishikawa、Keita Nagai、Hiroyasu Tsuge、Makoto Ando、Osamu Okamoto、Hisashi Iwaasa、Akira Gomori、Akane Ishihara、Akio Kanatani、Takehiro Fukami
    DOI:10.1016/j.bmcl.2009.01.101
    日期:2009.3
    Novel imidazoline derivatives were discovered to be potent neuropeptide Y Y5 receptor antagonists. High-throughput screening of Merck sample collections against the human Y5 receptor resulted in the identification of 2,4,4-triphenylimidazoline (1), which had an IC(50) of 54 nM. Subsequent optimization led to the identification of several potent derivatives. (C) 2009 Elsevier Ltd. All rights reserved.
查看更多